PharmaTech, a manufacturer of liquid docusate products, has expanded a voluntary recall of its products after an outbreak of Burkholderia cepacia (B. cepacia) infections.

The bacteria, a threat to individuals with weakened immune systems or chronic lung diseases, has been linked to a five-state outbreak.

In a July 16 announcement, the U.S. Food and Drug Administration (FDA) said PharmaTech, of Davie, Fla., voluntarily recalled all non-expired lots of Diocto Liquid, a docusate sodium solution distributed by Rugby Laboratories.

In an Aug. 9 alert, the FDA notified health care providers and consumers that the voluntary recall now applies to all of PharmaTech’s liquid products. The products are labeled by six firms: Bayshore, Centurion, Major, Metron, Rugby, and Virtus.

FDA said health care facilities, pharmacies, and consumers should stop using the products immediately.

Contact Director of Policy Erin O’Malley at eomalley@essentialhospitals.org or 202.585.0127 with questions.